Mankind, IPCA, Torrent, Ajanta, Sun Lead Pharma Market Growth In November

India's pharmaceutical market grew in November as sales recovered, aided by drugs used for chronic conditions from diabetes to heart diseases.

According to the AIOCD data:

• Sales of acute therapies such as gastro, respiratory and pain/analgesics rose 13.1%, 16.3% and 17.3%, respectively.

• Anti-infectives' sales contracted 1.1%.

• Chronic therapy sales of cardiac and anti-diabetic drugs rose 6.3% and 6%, respectively.

• The moving annual total, or 12-month rolling sales, of pharmaceutical products in the country rose 15.2% in November.

Sales of vaccines fell 12.5% year-on-year, impacting the overall MAT growth, Motilal Oswal said.

According to the brokerage:

• These companies grew more than the industry average: Mankind Pharma Ltd., IPCA Laboratories Ltd., Torrent Pharmaceuticals Ltd., Ajanta Pharma Ltd., Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Aristo Pharmaceuticals Pvt., Eris Lifesciences Ltd., Micro Labs Ltd. and Intas Pharmaceuticals Ltd.

• Glenmark Pharmaceuticals Ltd.'s sales fell 18% year-on-year amid a decline in demand for Covid therapies as new infections dropped.